Heather J. Litman

thermo fisher scientific

H指数:37

被引数:5,538

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study

类风湿关节炎合并慢性肾脏病患者中生物制剂和靶向合成治疗的有效性与持久性：一项多中心、前瞻性队列研究

The Lancet Rheumatology

IF0

2026-04-220

PRE

Features Associated with Therapy Switch Among PPD CorEvitas Psoriasis Registry Patients

Dermatology and Therapy

IF4.2

2026-01-190

OAAI

Development and External Validation of a Multivariable Predictive Model for Progression to Difficult-to-Treat Rheumatoid Arthritis in Biologic-Experienced Patients

生物制剂经治患者进展为难治性类风湿关节炎的多变量预测模型的发展与外部验证

ARTHRITIS CARE & RESEARCH

IF3.3

2025-10-010

PRE

Fracture in clinical studies of tofacitinib in rheumatoid arthritis

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE

IF4.1

2022-12-277

OAAI

Characterization of real-world psoriasis patients with and without a history of depression: The Corrona Psoriasis Registry

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2021-05-013

OAAI

Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry

DERMATOLOGY AND THERAPY

IF4.2

2021-01-213

OAAI

Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis

ADVANCES IN THERAPY

IF4

2020-10-0912

OAAI

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data

联合治疗达到类风湿性关节炎疾病控制后，生物DMARD单药治疗的持久性: corrona注册数据的回顾性分析

RHEUMATOLOGY INTERNATIONAL

IF2.9

2020-09-028

OAAI

Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry

JOURNAL OF RHEUMATOLOGY

IF3.4

2019-08-018

OAAI

Intimate Partner Relationships, Work-Life Factors, and Their Associations With Burnout Among Partnered Pediatric Residents

亲密伴侣关系，工作生活因素及其与儿科住院医师的倦怠的关系

ACADEMIC PEDIATRICS

IF2.8

2019-04-0110

PREAI

Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry

JOURNAL OF RHEUMATOLOGY

IF3.4

2018-07-015

OAAI

Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study

JOURNAL OF RHEUMATOLOGY

IF3.4

2017-11-0154

OAAI

THE IMPACT OF ANTI-CYCLIC CITRULLINATED PEPTIDE SEROPOSITIVITY ON EROSION PREVALENCE AMONG PATIENTS WITH RHEUMATOID ARTHRITIS OF VARYING DISEASE DURATION

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2017-06-010

OAAI

COMPARATIVE EFFECTIVENESS OF ABATACEPT VERSUS TNFI IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ARE CCP plus IN THE UNITED STATES CORRONA REGISTRY

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2017-06-010

OAAI

Pediatric Resident Burnout and Attitudes Toward Patients

PEDIATRICS

IF6.4

2017-03-01121

OAAI

Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis

儿童和青年溃疡性结肠炎内镜下疾病严重程度与儿童溃疡性结肠炎活动指数评分的相关性研究

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2017-01-0120

OAAI

NEED TO ADVANCE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TRIPLE NBDMARD VS BIOLOGIC COMBINATION THERAPY: RESULTS FROM THE CORRONA REGISTRY

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-010

PREAI

IMPACT OF ANTI-CYCLIC CITRULLINATED PEPTIDE AND RHEUMATOID FACTOR STATUS ON RESPONSE TO ABATACEPT THERAPY: FINDINGS FROM A US OBSERVATIONAL COHORT

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-013

PREAI

IS DISEASE DURATION AN INDEPENDENT PREDICTOR OF LOW DISEASE ACTIVITY/REMISSION AMONG BIOLOGIC-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT?

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-010

PREAI

RELATIONSHIP BETWEEN ANTI-CITRULLINATED PROTEIN ANTIBODY STATUS AND RESPONSE TO ABATACEPT OR ANTI-TUMOUR NECROSIS FACTOR THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A US NATIONAL OBSERVATIONAL STUDY

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2016-06-015

PREAI

Heather J. Litman

个人简介

教育背景

工作经历

荣誉奖项

研究方向